Christopher Rink, D.O. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 E College Ave, Bloomington, IL 61704 Phone: 309-661-6250 Fax: 309-451-1378 |
Mrs. Sara Aline Francois, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1505 Eastland Dr Ste 220, Bloomington, IL 61701 Phone: 309-662-2278 |
Dr. Nenita C Tudtud, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1015 S Mercer Ave, Bloomington, IL 61701 Phone: 309-662-7500 Fax: 309-662-7333 |
Won Jhee, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1015 S. Mercer Avenue, Suite E1, Bloomington, IL 61701 Phone: 309-662-7500 Fax: 309-662-7333 |
Jennifer Marie Hair, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1101 Elmwood Rd, Bloomington, IL 61701 Phone: 309-828-2909 |
News Archive
In the context of recent debate over the FDA's approval of aducanumab, it's refreshing to learn about a model of Alzheimer's neurodegeneration that doesn't start with the pathogenic proteins amyloid or Tau.
A team of researchers from the Yale University (United States) and a Spanish company have developed a system to detect the vapours emitted by human skin in real time. The scientists think that these substances, essentially made up of fatty acids, are what attract mosquitoes and enable dogs to identify their owners.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.
An international research team formed by a University of Cincinnati cancer researcher has shown for the first time that a specific enzyme is responsible for sensing the available supply of GTP, an energy source that fuels the uncontrolled growth of cancer cells. The research underscores the enzyme's potential to become a therapeutic target for future cancer drugs.
› Verified 5 days ago